Search results
Weight-Loss Drugmakers Are Overcharging By 400%; Here’s A Quick Solution
Forbes· 14 hours agoA whopping 1 in 8 U.S. adults have taken GLP-1 drugs like Wegovy and Ozempic for weight loss and...
Doctors must keep Ozempic prescriptions in check, Danish regulator says
Reuters via Yahoo News· 9 hours agoNorway meanwhile said it would tighten restrictions on the use of Ozempic, requiring doctors to seek...
Gateway - Quartz
Quartz· 6 days agoPharma giant AstraZeneca aims to increase its revenue by...Meanwhile, Pfizer announced Wednesday another cost-cutting initiative as the company struggles with diminishing ...
58% Of Patients Discontinue Use Of Obesity Meds Before Reaching Meaningful Weight Loss, Study Shows
Forbes· 5 days agoThere is high demand for obesity medications known as glucagon-like peptide-1 agonists, or GLP-1s. In conjunction with an appropriate diet and exercise regimen, GLP-1s can provide substantial ...
Texas patients turn to clinics for compounded semaglutide with Ozempic and WeGovy scarce | Texarkana...
Texarkana Gazette· 7 days agoWhen working out, dieting and even turning to other medications didn't help, she decided to try...
Health panel urges interventions for children and teens with high BMI
Washington Post via Yahoo News· 6 days agoWith obesity continuing to loom as a major public health threat, a leading panel of independent U.S....
Eli Lilly Has a New Drug That Could Push the Stock Higher
Motley Fool via Yahoo Finance· 4 days agoMedicare coverage Another reason to feel upbeat about the future of donanemab is that Medicare has...
Subtle victory for Sanders in Novo spat
Politico· 6 days agoCosts and benefits: The FDA said the annual benefits from the final rule will be approximately $3.5 million and the annualized costs will be about $3 million. A NEW RULE UNDER OMB REVIEW ...
The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly
Zacks via Yahoo Finance· 3 days agoDespite supply challenges, Wegovy is seeing strong prescription trends and is generating impressive...
SELECT: Semaglutide Reduces CV Events and Diabetes Risk
Medscape· 2 days agoThe glucagon-like peptide 1 (GLP-1) receptor agonist semaglutide (Wegovy, Ozempic) reduced...